Europe Hpv Testing And Pap Test Market Size & Outlook

The hpv testing and pap test market in Europe is expected to reach a projected revenue of US$ 2,305.9 million by 2030. A compound annual growth rate of 10.5% is expected of Europe hpv testing and pap test market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,149.6
Forecast, 2030 (US$M)
$2,305.9
CAGR, 2024 - 2030
10.5%
Report Coverage
Europe

Europe hpv testing and pap test market highlights

  • The Europe hpv testing and pap test market generated a revenue of USD 1,149.6 million in 2023.
  • The market is expected to grow at a CAGR of 10.5% from 2024 to 2030.
  • In terms of segment, pap test was the largest revenue generating type in 2023.
  • HPV Test is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.

Europe data book summary

Market revenue in 2023USD 1,149.6 million
Market revenue in 2030USD 2,305.9 million
Growth rate10.5% (CAGR from 2023 to 2030)
Largest segmentPap test
Fastest growing segmentHPV Test
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPap Test, HPV Test
Key market players worldwideAbbott Laboratories, Qiagen NV, Becton Dickinson & Co, Quest Diagnostics Inc, Hologic Inc, Roche Holding AG ADR, Femasys Inc, Thermo Fisher Scientific Inc, BioMerieux SA, Seegene, Arbor Vita Corporation, Nurx

Other key industry trends

  • In terms of revenue, Europe region accounted for 26.9% of the global hpv testing and pap test market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 2,190.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

HPV Testing And Pap Test Market Companies

Name Profile # Employees HQ Website

Europe hpv testing and pap test market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hpv testing and pap test market will help companies and investors design strategic landscapes.


Pap test was the largest segment with a revenue share of 62.49% in 2023. Horizon Databook has segmented the Europe hpv testing and pap test market based on pap test, hpv test covering the revenue growth of each sub-segment from 2018 to 2030.


  • Europe HPV Testing And Pap Test Type Outlook (Revenue, USD Million, 2018-2030)
    • Pap Test
    • HPV Test
  • Europe HPV Testing And Pap Test Application Outlook (Revenue, USD Million, 2018-2030)
    • Cervical Cancer Screening
    • Vaginal Cancer Screening
  • Europe HPV Testing And Pap Test Product Outlook (Revenue, USD Million, 2018-2030)
    • Instruments
    • Consumables
    • Services
  • Europe HPV Testing And Pap Test Technology Outlook (Revenue, USD Million, 2018-2030)
    • PCR
    • Immunodiagnostics
    • Other Technologies
  • Europe HPV Testing And Pap Test End Use Outlook (Revenue, USD Million, 2018-2030)
    • Hospitals & Clinics
    • Laboratories
    • Others

Reasons to subscribe to Europe hpv testing and pap test market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe hpv testing and pap test market databook

  • Our clientele includes a mix of hpv testing and pap test market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe hpv testing and pap test market , including forecasts for subscribers. This continent databook contains high-level insights into Europe hpv testing and pap test market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe hpv testing and pap test market size, by country, 2018-2030 (US$M)

Europe HPV Testing And Pap Test Market Outlook Share, 2023 & 2030 (US$M)

Europe hpv testing and pap test market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more